Catalyst Pharmaceuticals, Inc.
Florida
United States
352 articles about Catalyst Pharmaceuticals, Inc.
-
Catalyst Pharmaceutical Partners Reports First Quarter 2007 Financial Results
5/15/2007
-
Catalyst Pharmaceutical Partners Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's Investigational Drug to Treat Cocaine and Methamphetamine Addiction
5/9/2007
-
Catalyst Pharmaceutical Partners Names Vice President of Pharmaceutical Development and Project Management
4/4/2007
-
Catalyst Pharmaceutical Partners Reports Year-End 2006 Financial Results
4/3/2007
-
Catalyst Pharmaceutical Partners Strengthens Scientific Advisory Board With Appointment Of Richard A. Rawson, Ph.D.
2/14/2007
-
Catalyst Pharmaceutical Partners Adds Thomas Kosten, M.D. To Its Scientific Advisory Board
1/12/2007
-
Catalyst Pharmaceutical Partners Trial Delayed
1/3/2007
-
Catalyst Pharmaceutical Partners Announces Results Of Operations For 2006 Third Quarter
12/18/2006
-
Catalyst Pharmaceutical Partners Announces Closing Of Initial Public Offering
11/14/2006
-
IPO Watch: Is Catalyst Pharmaceutical Partners A Bargain At Half The Price?
11/10/2006
-
The Day In Review: News From The Hepatitis Front
10/27/2006
-
Catalyst Pharmaceutical Partners Appoints Chief Medical Officer And Vice President Of Regulatory Operations
9/7/2006